(Q28567411)

2

1 reference

31 January 2017

D. Ganeshapillai

3

1 reference

31 January 2017

L. W. Woo

4

1 reference

31 January 2017

B. V. Potter

5

1 reference

31 January 2017

M. J. Reed

The Journal of Steroid Biochemistry and Molecular Biology

6

1 reference

31 January 2017

language of work or name

1 reference

31 December 2000

1 reference

31 January 2017

1 reference

31 January 2017

75

1 reference

31 January 2017

253–258

1 reference

31 January 2017

4-5

1 reference

31 January 2017

In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Importance of estrogen sulfates in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Development of potent non-estrogenic estrone sulfatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Novel oestrogen sulfamates: a new approach to oral hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Non-steroidal and steroidal sulfamates: new drugs for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-O-sulphamate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021

Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900178-3

7 January 2021